En español
NIDA

NIDA Notes Articles: Clinical Trials Network

NIDA Notes Category Graphic

Dr. Phil Skolnick Now Leads NIDA's Medications Development Efforts

April 2010
Announces the appointment of Dr. Phil Skolnick as NIDA’s director of the Division of Pharmacotherapies and Medical Consequences of Drug Abuse.

NIDA Notes Category Graphic

Young Opioid Abusers Benefit From Extended Buprenorphine-Naloxone Treatment

April 2010
Reports on a study investigating the benefits of extended opioid maintenance therapy that included drug counseling and 12 weeks of therapy with buprenorphine and naloxone.

NIDA Notes Category Graphic

Incentives Reduce Stimulant Abuse During Methadone Maintenance

April 2007
Summarizes a study on the use of incentives to encourage abstinence among methadone maintenance patients in outpatient programs.

NIDA Notes Category Graphic

Addiction and Co-Occurring Mental Disorders

February 2007
Presents an overview of the research underway to investigate medication and behavioral therapies for co-occurring disorders.

NIDA Notes Category Graphic

Low-Cost Incentives Improve Outcomes in Stimulant Abuse Treatment

October 2006
Reports on a study investigating the use of incentives in the form of prizes to motivate outpatients to stay in behavioral therapy and remain drug free.

Pages

NIDA Notes

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics